Atacama Therapeutics, Inc.
Biotechnology company · Wellesley, Massachusetts, United States
Atacama Therapeutics, Inc. is a biotechnology company headquartered in Wellesley, Massachusetts, United States. It has reported private securities offerings to the US SEC, most recently $830,000 sold in a notice filed in 2024.
Profile compiled from public records. Is this your company? Request a correction or update
Atacama Therapeutics at a glance
Typebiotechnology company
HeadquartersWellesley, Massachusetts, United States
SEC CIK2022176
What does Atacama Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $830,000 sold (2024).
Frequently asked questions about Atacama Therapeutics
Where is Atacama Therapeutics headquartered?
Atacama Therapeutics, Inc. is headquartered in Wellesley, Massachusetts, United States.
What does Atacama Therapeutics do?
Atacama Therapeutics, Inc. is a biotechnology company.
Similar companies
- Mulberry Biotherapeutics, Inc.Wellesley, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences